Generation of a new immunodeficient rat model of retinal degeneration with LSL TdTomato reporter and TdTomato-Pcp2 expression

Researchers developed a novel immunodeficient rat model of retinal degeneration expressing a TdTomato reporter under Pcp2 control, which facilitates the study of transplant-host connectivity and serves as a versatile platform for generating cell-specific labeled models using the Cre/lox system.

The Gist

Imagine the human eye as a highly sophisticated camera. Inside this camera, there are tiny film cells called photoreceptors that capture light and send pictures to the brain. In diseases like Retinitis Pigmentosa or Macular Degeneration, these "film cells" slowly die off, leaving the camera with a blank screen and the person blind.

Scientists have been trying to fix this broken camera by transplanting new, healthy film cells (grown from stem cells) into the eye. But to see if the new cells actually connect and work with the old ones, they need a way to tell them apart. It's like trying to find a specific red thread in a pile of white yarn.

This paper describes the creation of a brand-new super-rat designed specifically to solve this problem. Here is the story of how they built it, explained simply:

1. The Problem: We Needed a "Glow-in-the-Dark" Host

To test new cell therapies, scientists use rats that have the same eye disease as humans. However, when they transplant new cells, it's hard to see where the new cells end and the old rat cells begin. They needed a rat where the old cells would light up in a specific color, so the new cells (which would be a different color) could be easily spotted.

2. The Solution: A Genetic "Switch" System

The scientists used a genetic tool called Cre-LoxP. Think of this like a sophisticated light switch system in a house:

• The Bulb (TdTomato): This is a gene that makes cells glow bright red. But, it comes with a "safety cover" (called LSL) that keeps it turned off.
• The Switch (Cre): This is a special protein that acts like a key. When it finds the safety cover, it removes it, turning the red light on.
• The Wiring (Pcp2): This is the instruction manual that tells the "Switch" (Cre) exactly where to go. In this case, the scientists wanted the red light to turn on only in specific nerve cells called bipolar cells (the middlemen that pass signals from the film to the brain).

3. Building the Super-Rat (The Recipe)

The scientists didn't just buy this rat; they had to bake it from scratch using two different ingredients:

• Ingredient A (The Broken Camera with a Red Bulb): They took a rat that already had a broken eye (retinal degeneration) and injected it with the "Bulb" gene (the red light that is currently covered). They made sure this rat had no immune system (like a "nude" rat), so it wouldn't reject future transplants.
• Ingredient B (The Key Maker): They created a second rat that produces the "Switch" (Cre). They tried to make this switch work on the original broken rat, but it failed. So, they switched to a different breed of rat (Long-Evans) and successfully made a rat that carries the "Switch."

The Final Mix: They mated Ingredient A and Ingredient B.

• The babies (F1 generation) inherited the broken eye, the red bulb, and the switch.
• The Result: In these baby rats, the "Switch" went to work, removing the safety cover on the red bulb. Now, the specific nerve cells in their eyes glow bright red.

4. The Surprise: Two Versions of the Switch

The scientists found two types of these new rats:

1. The "Precise" Rat: The switch went exactly where they wanted. Only the middleman nerve cells (bipolar cells) glowed red. This is the perfect model for studying specific connections.
2. The "Messy" Rat: The switch landed in random spots. It turned on the red light in the nerve cells, but also in the skin of the eye, the blood vessels, and the support cells. While not perfect for specific studies, it still showed that the system works.

5. The Test Drive: The Transplant Experiment

To prove this new rat was useful, the scientists performed a "test drive."

• They took healthy retinal tissue from a different rat that glowed Green.
• They surgically implanted this green tissue into the eye of their new "Red-Glowing" rat.
• The Magic: Because the host rat's cells were red and the transplant was green, the scientists could clearly see the two groups of cells meeting. They saw the green cells sending out "fingers" (processes) to touch the red cells, and the red cells reaching out to the green ones.

Why This Matters

Think of this new rat as a high-contrast map. Before, trying to see if a transplant connected to the host was like trying to find a needle in a haystack where both the needle and the hay were the same color. Now, the hay is glowing red, and the needle is glowing green.

This model allows scientists to:

• See the connection: Watch exactly how new cells hook up to the old brain circuitry.
• Test cures: See if new stem cell therapies actually work in a larger animal (rats have bigger eyes than mice, making surgery easier and more similar to humans).
• Future-proof: Because they used the "Switch" system, they can now easily swap the "Switch" to turn on red lights in any other type of eye cell, making this a versatile tool for future research.

In short, these scientists built a glowing, blind rat that acts as a perfect testing ground for fixing human blindness, giving researchers a clear, colorful view of how to repair the eye's wiring.

Technical Summary

1. Problem Statement

Retinal degeneration (RD) diseases, such as Retinitis Pigmentosa (RP) and Age-Related Macular Degeneration (AMD), lead to irreversible blindness. While mouse models are abundant, rat models offer distinct advantages for translational research, including larger ocular anatomy, better suitability for surgical manipulation (e.g., subretinal transplantation), and superior performance in behavioral visual testing. However, there is a lack of well-characterized, immunodeficient rat models that combine:

• Severe retinal degeneration.
• Cell-specific fluorescent labeling (to distinguish host cells from transplanted cells).
• The ability to accept xenotransplants (human cells) without immune rejection.

Existing models often lack the specific genetic tools (Cre/LoxP systems) required to visualize specific retinal circuits (like bipolar cells) in the context of degeneration and transplantation.

2. Methodology

The authors employed a multi-step genetic engineering strategy to create a novel hybrid rat strain:

• Strain 1: Immunodeficient RD Reporter (RNT)

  • Base Strain: Immunodeficient RhoS334ter-3 rats (RRRC#539), which carry a dominant rhodopsin mutation causing rapid photoreceptor degeneration and the Foxn1 mutation (nude phenotype).
  • Modification: Using Zinc Finger Nucleases (ZFNs), the authors inserted a CAG-LSL-TdTomato construct into the rROSA safe harbor locus.
  • Mechanism: The "LSL" (Lox-Stop-Lox) cassette prevents TdTomato expression until Cre recombinase is present.
  • Outcome: A homozygous strain (SD-Foxn1rnuTg((Rho-S334X)3,CAG-TdTomato)1010Mjsuc) that is immunodeficient, degenerative, and universally carries the reporter but does not express fluorescence until crossed with a Cre-driver.

• Strain 2: Cell-Specific Cre Driver (Pcp2-Cre)

  • Base Strain: Long-Evans (LE) rats (initial attempts on the immunodeficient background failed).
  • Modification: Using CRISPR-Cas9, the authors targeted the Pcp2 (Purkinje cell protein 2) locus to insert a Cre recombinase gene.
  • Outcome: Two founder lines were generated. One had targeted integration (Cre expressed only under the Pcp2 promoter), while the other had random integration (Cre expressed ectopically). These were bred to homozygosity and crossed with NIH nude rats to ensure immunodeficiency.

• Generation of the Final Model ("RTP" Rats)

  • Homozygous RNT rats were crossed with homozygous Pcp2-Cre rats.
  • Result: The F1 offspring ("RTP" rats) are immunodeficient (Foxn1-/-), exhibit severe retinal degeneration, and express TdTomato specifically in cells where Pcp2 is active (due to Cre-mediated recombination of the LSL cassette).

• Validation & Pilot Studies

  • Genotyping: PCR and gel electrophoresis were used to confirm zygosity and integration sites (targeted vs. random).
  • Immunohistochemistry: Retinas were stained with markers for various cell types (e.g., PKCα for rod bipolar cells, Secretagogin for cone bipolar cells, CRALBP for Müller glia) to map TdTomato expression.
  • Visual Testing: Optokinetic tracking (OKT) was used to measure visual acuity decline over time.
  • Transplantation Pilot: GFP-expressing rat fetal retinal sheets were transplanted into the subretinal space of 6-week-old RTP rats to test host-graft connectivity.

3. Key Contributions

• Novel Immunodeficient RD Rat Model: Creation of the "RNT" strain, a foundational tool for generating cell-specific labeled RD rats via the Cre/LoxP system.
• Cell-Specific Labeling in Degenerating Retinas: Successful generation of "RTP" rats where host bipolar cells are fluorescently labeled (TdTomato), allowing clear visualization of the transplant-host interface.
• Species Comparison: The study highlights a critical species difference: while Pcp2 drives Cre expression in rod bipolar cells in mice, in these rats, it primarily labels cone bipolar cells and some cone photoreceptors.
• Translational Platform: The model is specifically designed to facilitate xenotransplantation studies (e.g., human retinal organoids) by combining immunodeficiency with a fluorescent host background to track integration without immunosuppression.

4. Results

• Genetic Characterization:
  • RNT Strain: Successfully generated homozygous immunodeficient rats with the CAG-LSL-TdTomato transgene. Visual acuity declined significantly between 4 and 8 months of age.
  • Pcp2-Cre Strain: Two founders identified. One showed targeted integration; the other showed both targeted and random integration.
  • RTP Cross: F1 offspring were heterozygous for both transgenes and expressed TdTomato.
• Expression Patterns:
  • Targeted Integration (Pcp2-Cre #1105): TdTomato expression was restricted primarily to cone bipolar cells (co-localized with Secretagogin) and scattered cone photoreceptors. There was minimal overlap with rod bipolar markers (PKCα).
  • Random Integration (Pcp2-Cre #1105): TdTomato was expressed ectopically in Retinal Pigment Epithelium (RPE), Müller glia, astrocytes, endothelial cells (blood vessels), and some photoreceptors. This "leaky" expression served as a warning for phenotypic screening (e.g., pink skin/hair).
• Degeneration Timeline: In RTP rats, the Outer Nuclear Layer (ONL) reduced from ~2.5 rows at Postnatal Day 19 (P19) to <1 row by P35, mimicking the rapid degeneration of the parental RhoS334ter-3 strain.
• Transplantation Pilot:
  • GFP-transplanted retinal sheets survived in RTP hosts.
  • Connectivity: Host processes (labeled by TdTomato) extended into the graft, and graft processes extended into the host Inner Nuclear Layer (INL).
  • Vascularization: Host-derived blood vessels (TdTomato+) extended into the transplant.
  • Differentiation: In random-expression hosts, the transplant developed photoreceptor outer segments contacting the host RPE.

5. Significance

• Advancing Cell Therapy: This model provides a robust platform for evaluating the efficacy of retinal organoid transplantation. The fluorescent host background allows researchers to precisely quantify synaptic integration and cellular migration between the graft and the host retina, which is difficult to assess in non-fluorescent models.
• Xenotransplantation Feasibility: By utilizing the Foxn1 mutation (nude rats), the model eliminates the need for systemic immunosuppression, which is often toxic and confounding in long-term studies. This is crucial for testing human stem cell-derived therapies.
• Circuit Mapping: The ability to label specific interneurons (bipolar cells) in a degenerating retina helps researchers understand how the remaining retinal circuitry reorganizes or adapts during disease progression.
• Resource Availability: The authors have submitted the strain to the Rat Research Resource Center (RRRC), ensuring availability for the broader scientific community to study retinal degeneration and transplantation.

In summary, this paper describes the successful engineering of a versatile, immunodeficient rat model that combines severe retinal degeneration with cell-specific fluorescent labeling, significantly enhancing the capacity to study and optimize retinal transplantation therapies.